2008

Chavant F, Lafay-Chebassier C, Beauchant M, Pérault-Pochat MC. Hépatite à la doxycycline : à propos d’un cas. Gastroenterol Clin Biol. 2008 (French).

Deguil J, Perault-Pochat MC, Chavant F, Lafay-Chebassier C, Fauconneau B, Pain S. Activation of the protein p70S6K via ERK phosphorylation by cholinergic muscarinic receptors stimulation in human neuroblastoma cells and in mice brain. Toxicol. Lett. 2008, 182(1-3):91-6.

Beato R, Levy R, Pillon B, Vidal C, du Montcel ST, Deweer B, Bonnet AM, Houeto JL, Dubois B, Cardoso F. Working memory in Parkinson’s disease patients : clinical features and response to levodopa. Arq Neuropsiquiatr. 2008, 66(2a):147-151.

Lohmann E, Welter ML, Fraix V, Krack P, Lesage S, Laine S, Tanguy ML, Houeto JL, Mesnage V, Pollak P, Durr A, Agid Y, Brice A ; French Parkinson’s Disease Genetics study group. Are parkin patients particularly suited for deep-brain stimulation ? Mov Disord. 2008, 23(5):740-3.

Houeto JL, Giré P. [Tics and Tourette syndrome : diagnosis, course and treatment principles.] Presse Med. 2008, 37(2 Pt 2):263-70. Review. French.

Wager M, Menei P, Guilhot J, Levillain P, Michalak S, Bataille B, Blanc JL, Lapierre F, Rigoard P, Milin S, Duthe F, Bonneau D, Larsen CJ, Karayan-Tapon L. Prognostic molecular markers with no impact on decision-making : the paradox of gliomas based on a prospective study. Br J Cancer. 2008, 98(11):1830-8.

Pain S, Barrier L, Deguil J, Milin S, Piriou A, Fauconneau B, Page G. A cell-permeable peptide inhibitor TAT-JBD reduces the MPP+-induced caspase-9 activation but does not prevent the dopaminergic degeneration in substantia nigra of rats. Toxicology. 2008, 243(1-2):124-37.

Recherche

Menu principal

Haut de page